Skip navigation
Please use this identifier to cite or link to this item: http://arks.princeton.edu/ark:/88435/dsp01gf06g536h
Full metadata record
DC FieldValueLanguage
dc.contributor.authorWorld Anti-Doping Agency (WADA)-
dc.date.accessioned2018-06-14T18:11:00Z-
dc.date.available2018-06-14T18:11:00Z-
dc.date.issued2017-10-
dc.identifier.urihttp://arks.princeton.edu/ark:/88435/dsp01gf06g536h-
dc.descriptionThe exclusive purpose of this medical information is to define the criteria for granting a Therapeutic Use Exemption (TUE) for the treatment with substances on the Prohibited List to transgender athletes. It is not the purpose of this medical information to define the criteria for the eligibility of these athletes to participate in competitive sport, which is entirely left to the different sporting federations and organizations.en_US
dc.language.isoen_USen_US
dc.relation.urihttps://www.wada-ama.org/en_US
dc.subjecttransgenderen_US
dc.subjectathletesen_US
dc.subjectTherapeutic Use Exemption (TUE)en_US
dc.subjecttranssexualen_US
dc.subjectfemale to male (FtM)en_US
dc.subjectmale to female (MtF)en_US
dc.subjectgender-nonconformingen_US
dc.subjecttranswomen, transmenen_US
dc.titleTransgender Athletesen_US
dc.title.alternativeTherapeutic Use Exemption (TUE) PHYSICIAN GUIDELINES Medical Information to Support the Decisions of TUE Committeesen_US
pu.projectgrantnumber690-1011-
pu.depositorCordonnier, Deborah-
dc.publisher.placeMontreal, Canadaen_US
dc.publisher.corporateWorld Anti-Doping Agencyen_US
Appears in Collections:Monographic reports and papers (Publicly Accessible)

Files in This Item:
File Description SizeFormat 
wada_transgender_athletes.pdf152.21 kBAdobe PDFView/Download


Items in Dataspace are protected by copyright, with all rights reserved, unless otherwise indicated.